Clin2
NCT06404671Possibly a fitRecruiting

Timing of surgery after chemo for advanced ovarian cancer

Ovarian Epithelial Cancer

Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.

This trial tests whether waiting longer between chemotherapy and surgery affects outcomes for advanced ovarian cancer. It is for women who have had three cycles of chemo and whose disease can be removed surgically.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
250 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are a woman aged 18 to 75.
  • You have advanced high-grade serous ovarian, fallopian tube, or primary peritoneal cancer that cannot be fully removed with surgery upfront.
  • You have had three cycles of chemotherapy and your disease can be surgically removed as seen by laparoscopic evaluation.
  • You are in good general health (ECOG performance status 0 or 1) and your organs are working well enough for surgery.
  • You have no other active cancer or serious medical conditions like recent stroke or uncontrolled illness.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07382479Not yet recruiting
Timing of Surgery After Chemotherapy for Ovarian Cancer

This trial compares two timing options for surgery after chemotherapy in advanced ovarian cancer. The goal is to see if delaying surgery based on a blood test (KELIM) leads to better outcomes.

NCT07023484Recruiting· Phase 2
Timing of ovarian cancer surgery after chemo

This study looks at whether the timing of surgery after chemotherapy can be personalized for advanced ovarian cancer. It uses a blood test (CA125) to help decide the best time for surgery, aiming to improve outcomes.

Guangzhou
NCT07068464Not yet recruiting· Phase 3
ICRA Trial: timing of surgery for ovarian cancer

This trial is for women with advanced ovarian cancer that cannot be removed completely at first. It tests if having surgery after three rounds of chemotherapy is beneficial.

London
NCT07022535Recruiting· Phase 2
Personalized timing of surgery for advanced ovarian cancer

This trial checks if adjusting the timing of surgery (interval debulking surgery) after chemotherapy can improve outcomes for people with advanced ovarian cancer. It's for those who cannot have surgery right away and will receive chemotherapy first.

Hong Kong
NCT04515602Not yet recruiting· Phase 3
Compare surgery timing with chemotherapy in advanced ovarian cancer

This Phase 3 trial tests whether patients with advanced ovarian, fallopian tube, or primary peritoneal cancer do better with surgery first versus chemotherapy first. It also groups people based on how extensive the cancer is to choose the best approach.

Shanghai, Shanghai Municipality
NCT06883409Recruiting
Laparoscopic surgery for advanced ovarian cancer after chemo

This trial tests if laparoscopic surgery after 3-4 cycles of chemotherapy can help people with advanced epithelial ovarian cancer. It's for those whose tumors have shrunk enough after chemo and who are healthy enough for surgery.

México, Tlalpan

Hear when a new Ovarian Epithelial Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.